SYNGENE — Syngene International Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Syngene International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20,119	21,843	26,042	31,929	34,886
Cost of Revenue
Gross Profit	14,467	16,004	17,904	22,635	24,887
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	16,277	17,691	22,033	25,757	28,529
Operating Profit	3,842	4,152	4,009	6,172	6,357
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,169	4,692	4,844	5,936	6,208
Provision for Income Taxes
Net Income After Taxes	4,121	4,049	3,958	4,644	5,100
Net Income Before Extraordinary Items
Net Income	4,121	4,049	3,958	4,644	5,100
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,121	4,049	3,958	4,644	5,100
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	8.92	9.35	10.4	11.7	13
Dividends per Share
Special Dividends per Share